Efavirenz failure

Efavirenz is associated with a low rate of serum enzyme elevations during therapy and is an uncommon, but well established cause of clinically apparent acute liver injury. efavirenz decreases levels of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism

2024-03-29
    Fluconazol erythromycin
  1. Typically, improvements start
  2. 33%; P=0
  3. 2001 Aug 9;345 (6):398-407